BOSTON — DivcoWest has secured another significant office lease at One Lincoln, with Collegium Pharmaceutical signing a 40,288-square-foot lease to relocate its corporate headquarters to the recently repositioned office tower in Boston’s Financial District.
The biopharmaceutical company will occupy the 11th and 12th floors of the 36-story, 1.1 million-square-foot building, marking another notable lease at One Lincoln following the completion of an extensive property-wide renovation in 2025.
The transaction underscores continued demand for premium, amenity-rich office space in downtown Boston, particularly among companies seeking to upgrade their workplace environments as market conditions continue to favor tenants.
“Welcoming a life sciences leader like Collegium Pharmaceutical to One Lincoln speaks to the versatility of this building and its ability to serve companies across industries,” said Mark Roopenian, Managing Director at DivcoWest. “Collegium’s decision reflects everything One Lincoln has to offer, from an elevated workplace experience to an unmatched location just steps from South Station. As companies continue to prioritize spaces that support collaboration and employee experience, we’re proud to offer a workplace that meets those evolving needs and look forward to this partnership.”
Collegium develops medicines using advanced formulation and delivery technologies to treat patients with complex central nervous system and pain conditions. Company officials cited One Lincoln’s central location, proximity to South Station, and extensive tenant amenities as key factors in its relocation decision.
The lease further strengthens One Lincoln’s diverse tenant roster, which includes private markets investment firm HarbourVest, artificial intelligence company Lovable, law firm Sherin and Lodgen, advisory firm CFGI, and flexible workspace provider WeWork.
According to the brokerage team representing Collegium, the relocation reflects a broader trend emerging across the Greater Boston office market, where occupiers are capitalizing on favorable leasing conditions to secure higher-quality office space in prime urban locations.
“This relocation reflects a broader trend we’re seeing across Greater Boston,” said Justin Dziama, Principal at Avison Young. “As market conditions have shifted, companies are taking advantage of the opportunity to upgrade their workplace experience, improve accessibility for employees, and establish a stronger presence in the urban core. For Collegium, One Lincoln provided the chance to accomplish all of those goals in one move.”
Originally developed as one of Boston’s premier Class A office towers, One Lincoln has undergone a comprehensive repositioning designed to meet evolving tenant expectations. The renovation introduced a robust suite of hospitality-inspired amenities, including a two-story health and wellness club, tenant dining facilities, conference and meeting spaces, wellness suites, game rooms, and a rooftop recreation area featuring basketball and pickleball courts.
“Collegium’s lease underscores the momentum behind One Lincoln and the continued demand for well-located, highly activated office environments,” said Gil Dailey, Executive Managing Director at Newmark. “The building has quickly established itself as a compelling option for tenants seeking a dynamic Boston workplace that supports both their people and their business.”
Strategically located in Boston’s Financial District, One Lincoln offers immediate access to South Station, Interstate 93, the Massachusetts Turnpike, and Boston Logan International Airport, making it one of the city’s most connected office destinations.
Gil Dailey and Dave Martel of Newmark represented DivcoWest in the lease transaction, while Justin Dziama and Connor Hayes of Avison Young represented Collegium Pharmaceutical.
